NPY and breast cancer: Neuropeptide Y and neuropeptide Y receptors 1 and 5 are highly expressed in BC [191], and neuropeptide Y receptor 5 antagonists (CGP71,683A) inhibited both BC cell growth and migration and also promoted the death of BC cells expressing neuropeptide Y receptor 5 [193].